Pitavastatin Magnesium is a statin medication used mainly to treat adults with primary hyperlipidemia or mixed dyslipidemia by lowering “bad” cholesterol (LDL) and triglycerides while slightly raising “good” cholesterol (HDL). It is available under the brand name Zypitamag and is taken orally, usually once daily. It works by inhibiting the enzyme HMG-CoA reductase in the liver, that is responsible for cholesterol production. It is grouped under the following drug class(es): Cholesterol-reducing agents, Lipid-lowering agents and Statins. Its therapeutic use is listed as cardiovascular. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Zypitamag, 6-Heptenoic acid, 7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl)-3, 5-dihydroxy-, magnesium salt (2:1), (3R, 5S and 6E)-. Its PubChem CID is 25069056.
Pitavastatin magnesium
| CAS No | 956116-90-8 |
|---|---|
| Molecular Formula | C50H46F2MgN2O8 |
| Molecular Weight | 865.2 g/mol |
| Synonyms | magnesium;(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pitavastatin Magnesium is a statin medication used mainly to treat adults with primary hyperlipidemia or mixed dyslipidemia by lowering "bad" cholesterol (LDL) and triglycerides while slightly raising "good" cholesterol (HDL).
The listed CAS number is 956116-90-8.
The listed molecular formula is C50H46F2MgN2O8.
The listed molecular weight is 865.2 g/mol.
magnesium;(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate.
The source lists Zypitamag, 6-Heptenoic acid, 7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl)-3, 5-dihydroxy-, magnesium salt (2:1), (3R, 5S and 6E)-.